FNBP1 ПРИ ХРОНІЧНІЙ МІЄЛОЇДНІЙ ЛЕЙКЕМІЇ: ПРОСТОРОВА АСОЦІАЦІЯ З BCR-ABL ТА ПОТЕНЦІЙНІ МОЖЛИВОСТІ ДЛЯ ТАРГЕТНОЇ ТЕРАПІЇ
Background. Chronic myeloid leukemia (CML) develops as a result of the appearance of the oncoprotein BCR-ABL, which, due to its tyrosine kinase activity, leads to abnormal cellular signal transduction and blast transformation. fNBP1 is a protein involved in cytoskeletal remodeling, endocytosis, phag...
Saved in:
| Date: | 2026 |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
PH Akademperiodyka
2026
|
| Subjects: | |
| Online Access: | https://exp-oncology.com.ua/index.php/Exp/article/view/616 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Experimental Oncology |
| Download file: |  |